Astrocyte activation: A key step in rotenone induced cytotoxicity and DNA damage

Neurochemical Research

Volumn 37, Issue 10, 2012, Pages 2178-2189

  Swarnkar, Supriya ^a   Singh, Sarika ^a   Goswami, Poonam ^a   Mathur, Ramesh ^b   Patro, Ishan K ^b   Nath, Chandishwar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b JIWAJI UNIVERSITY   (India)

Author keywords

Apoptosis; Caspase 3; Glial activation; Glial fibrillary acidic protein (GFAP); Melatonin; Rotenone

Indexed keywords

BETA ACTIN; CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; MELATONIN; ROTENONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL STRUCTURE; CELL SURVIVAL; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG ACTIVITY; GLIA CELL; IMMUNOCYTOCHEMISTRY; MACROGLIA; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ASTROCYTES; BASE SEQUENCE; CELL LINE, TUMOR; COMET ASSAY; DNA DAMAGE; DNA PRIMERS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; RATS; REACTIVE OXYGEN SPECIES; ROTENONE;

RATTUS;

EID: 84866729431     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0841-y     Document Type: Article

References (43)

1. Radad K, Rausch WD, Gille G (2006) Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem Int 49:379-386
2. Cicchetti F, Drouin-Ouellet J, Gross RE (2009) Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30:475-483
3. Kitamura Y, Inden M, Miyamura A, Kakimura J, Taniguchi T, Shimohama S (2002) Possible involvement of both mitochondria and endoplasmic reticulum-dependent caspase pathways in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci Lett 333:25-28
4. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT (2003) Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23:10756-10764
5. Swarnkar S, Singh S, Mathur R, Patro IK, Nath C (2010) A study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats. Toxicology 272:17-22
6. Watabe M, Nakaki T (2004) Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells. J Pharmacol Exp Ther 311:948-953
7. Sakahira H, Enari M, Nagata S (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96-99
8. Sriram K, O'Callaghan JP (2005) Signaling mechanisms underlying toxicant-induced gliosis. In: Aschner M, Costa LG (eds) The role of Glia in neurotoxicity, 2nd edn. CRC Press, Boca Raton, pp 141-171
9. Eddleston M, Mucke L (1993) Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J 7:1226-1232
10. Zhou Y, Wang Y, Kovacs M, Jin J, Zhang J (2005) Microglial activation induced by neurodegeneration: a proteomic analysis. Mol Cell Proteomics 4:1471-1479
11. Rice-Evans C, Burdon R (1993) Free radical-lipid interactions and their pathological consequences. Prog Lipid Res 32:71-110
12. Bissel MG, Rubinstein LJ, Bignami A, Herman MM (1974) Characterization of the rat C6 glioma maintained in organ culture systems. Production of glial fibrillary acidic protein in the absence of gliofibrillogenesis. Brain Res 82:77
13. Esposito E, Iacono A, Muia C, Crisafulli C, Mattace-Raso G, Bramanti P, Meli R, Cuzzocrea S (2008) Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 44:78-87
14. Feng Z, Zhang J (2004) Protective effect of melatonin on β-amyloid-induced apoptosis in rat astroglioma C6 cells and its mechanism. Free Radic Biol Med 37:1790-1801
15. Swarnkar S, Tyagi E, Agrawal R, Singh MP, Nath C (2009) A comparative study on oxidative stress induced by LPS and rotenone in homogenates of rat brain areas. Environ Toxicol Pharmacol 27:219-224
16. Wang XJ, Xu JX (2005) Possible involvement of Ca2 + signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci Lett 376:127-132
17. James SJ, Slikker W III, Melnyk S, New E, Pogribna M, Jernigan S (2005) Thimerosal neurotoxicity is associated with glutathione depletion, protection with glutathione precursors. Neurotoxicology 26:1-8
18. Brana C, Benham C, Sundstrom L (2002) A method for characterising cell death in vitro by combining propidium iodide staining with immunohistochemistry. Brain Res Protocols 10:109-114
19. Ryu JK, Nagai A, Kim J, Lee MC, McLarnon JG, Kim SU (2003) Microglial activation and cell death induced by the mitochondrial toxin 3-nitropropionic acid, in vitro and in vivo studies. Neurobiol Dis 12:121-132
20. Peshavariya HM, Dusting GJ, Selemidis S (2007) Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic Res 41:699-712
21. Buschini A, Alessandrini C, Martino A, Pasini L, Rizzoli V, Carlo-Stella C, Poli P, Rossi C (2002) Bleomycin genotoxicity and amifostine [WR-2721] cell protection in normal leukocytes vs. K562 tumoral cells. Biochem Pharmacol 63:967-975
22. Abramoff M, Magelhaes P, Ram S (2004) Image processing with image. J Biophotonics Int 11:36-42
23. Lowry OH, Rosebrough NJ, Farr AI, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
24. Talpade DJ, Greene JG, Higgins DS, Greenamyre JT Jr (2000) In vivo labeling of mitochondrial complex I (NADH: ubiquinone oxidoreductase) in rat brain using [(3)H] dihydrorotenone. J Neurochem 75:2611-2621
25. Zhang HM, Zhang Y, Zhang BX (2011) The role of mitochondrial complex III in melatonin-induced ROS production in cultured mesangial cells. J Pineal Res 50:78-82
26. Lin AM, Ho LT (2000) Melatonin suppresses iron-induced neurodegeneration in rat brain. Free Radic Biol Med 28:904-911
27. Chao CC, Hu SX, Ehrlich L, Peterson PK (1995) Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9:355-365
28. Bonmann E, Suschek C, Spranger M, Kolb-Bachofen V (1997) The dominant role of exogenous or endogenous interleukin-1 beta on expression and activity of inducible nitric oxide synthase in rat microvascular brain endothelial cells. Neurosci Lett 230:109-112
29. Liu B, Hong JS (2003) Role of microglia in inflammation mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1-7
30. Aldskogius H, Kozlova EN (1998) Central neuron-glial and glial-glial interactions following axon injury. Prog Neurobiol 55:1-26
31. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318
32. Rossi DJ, Brady JD, Mohr C (2007) Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 10:1377-1386
33. Singh S, Dikshit M (2007) Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide. Brain Res Rev 54(2): 233-250
34. Radad K, Gille G, Rausch WD (2008) Dopaminergic neurons are preferentially sensitive to long term rotenone toxicity in primary culture. Toxicol in Vitro 22:68-74
35. Samantaray S, Knaryan VH, Guyton MK, Matzelle DD, Ray SK, Banik NL (2007) The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 146:741-755
36. Wiseman H, Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313:17-29
37. Shimohama S, Tanino H, Fujimoto S (2001) Differential expression of rat brain caspase family proteins during development and aging. Biochem Biophys Res Commun 289:1063-1066
38. Sharma R, McMillan CR, Tenn CC, Niles LP (2006) Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease. Brain Res 1068:230-236
39. Capitelli C, Sereniki A, Lima MM, Reksidler AB, Tufik S, Vital MA (2008) Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats. Eur J Pharmacol 594: 101-108
40. Joo WS, Jin BK, Park CW, Maeng SH, Kim YS (1998) Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats. NeuroReport 9:4123-4126
41. Tan DX, Manchester LC, Reiter RJ, Cabrera J, Burkhardt S, Phillip T, Gitto E, Karbownik M, Li QD (2000) Melatonin suppresses autoxidation and hydrogen peroxide-induced lipid peroxidation in monkey brain homogenate. Neuro Endocrinol Lett 21:361-365
42. Ortega-Gutiérrez S, Fuentes-Broto L, García JJ, López-Vicente M, Martínez-Ballarín E, Miana-Mena FJ, Millán-Plano S, Reiter RJ (2007) Melatonin reduces protein and lipid oxidative damage induced by homocysteine in rat brain homogenates. J Cell Biochem 102:729-735
43. Chen LJ, Gao YQ, Li XJ, Shen DH, Sun FY (2005) Melatonin protects against MPTP/MPP+-induced mitochondrial DNA oxidative damage in vivo and in vitro. J Pineal Res 39:34-42